Search icon

PFIZER INC.

Company claim

Is this your business?

Get access!

Company Details

Name: PFIZER INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 25 Jun 1951 (74 years ago)
Entity Number: 69033
ZIP code: 10005
County: New York
Place of Formation: Delaware
Principal Address: 66 Hudson Boulevard East, NEW YORK, NY, United States, 10017
Address: 28 LIBERTY ST., NEW YORK, NY, United States, 10005

Contact Details

Phone +1 212-733-2323

Agent

Name Role Address
C T CORPORATION SYSTEM Agent 28 LIBERTY ST., NEW YORK, NY, 10005

DOS Process Agent

Name Role Address
PFIZER INC. DOS Process Agent 28 LIBERTY ST., NEW YORK, NY, United States, 10005

Chief Executive Officer

Name Role Address
ALBERT BOURLA Chief Executive Officer 66 HUDSON BOULEVARD EAST, NEW YORK, NY, United States, 10017

Commercial and government entity program

CAGE number:
86491
Status:
Active
Type:
U.S./Canada Manufacturer
CAGE Update Date:
2024-08-15
CAGE Expiration:
2029-08-15
SAM Expiration:
2025-08-13

Contact Information

POC:
TINA DINDYAL

History

Start date End date Type Value
2025-06-19 2025-06-19 Address 235 EAST 42ND STREET, NEW YORK, NY, 10017, 5703, USA (Type of address: Chief Executive Officer)
2025-06-19 2025-06-19 Address 66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10017, USA (Type of address: Chief Executive Officer)
2025-06-19 2025-06-19 Address 66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001, 2192, USA (Type of address: Chief Executive Officer)
2023-06-29 2023-06-29 Address 235 EAST 42ND STREET, NEW YORK, NY, 10017, 5703, USA (Type of address: Chief Executive Officer)
2023-06-29 2023-06-29 Address 66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10017, USA (Type of address: Chief Executive Officer)

Filings

Filing Number Date Filed Type Effective Date
250619000354 2025-06-19 BIENNIAL STATEMENT 2025-06-19
230629001882 2023-06-29 BIENNIAL STATEMENT 2023-06-01
210727001159 2021-07-27 BIENNIAL STATEMENT 2021-07-27
190605060901 2019-06-05 BIENNIAL STATEMENT 2019-06-01
SR-1137 2019-01-28 CERTIFICATE OF CHANGE (BY AGENT) 2019-01-28

USAspending Awards / Contracts

Procurement Instrument Identifier:
36E79725D0032
Award Or Idv Flag:
IDV
Action Obligation:
0.00
Base And All Options Value:
74038216.80
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2025-09-15
Description:
NEW AWARD FOR RITUXIMAB WITH PFIZER INC. BASE YEAR ORDERING PERIOD IS SEPTEMBER 15, 2025 TO SEPTEMBER 14, 2026 WITH FOUR ONE-YEAR OPTIONS.
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS
Procurement Instrument Identifier:
36E79725D0030
Award Or Idv Flag:
IDV
Action Obligation:
0.00
Base And All Options Value:
46893140.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2025-08-13
Description:
NEW AWARD FOR BEVACIZUMAB INJECTIONS WITH PFIZER, INC. ORDERING PERIOD IS AUGUST 13, 2025 TO AUGUST 12, 2026 WITH FOUR ONE-YEAR OPTIONS
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS
Procurement Instrument Identifier:
75D30125D20474
Award Or Idv Flag:
IDV
Action Obligation:
9175.00
Base And All Options Value:
458750000.00
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2025-06-01
Description:
ADULT COVID VACCINES
Naics Code:
325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product Or Service Code:
6505: DRUGS AND BIOLOGICALS

Trademarks Section

Serial Number:
88489598
Mark:
ARMERUS
Status:
ABANDONED - AFTER PUBLICATION
Mark Type:
TRADEMARK
Application Filing Date:
2019-06-26
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
ARMERUS

Goods And Services

For:
Pre-filled and pre-assembled bottles and vials sold filled with pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerativ...
International Classes:
005 - Primary Class
Class Status:
Abandoned
Serial Number:
88489592
Mark:
VIALSURE
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2019-06-26
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
VIALSURE

Goods And Services

For:
Pre-filled and pre-assembled bottles and vials sold filled with pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerativ...
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
88488245
Mark:
SWIRV
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2019-06-25
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
SWIRV

Goods And Services

For:
Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; Medical apparatus, namely, infusion and injection devices for administering drugs
International Classes:
010 - Primary Class
Class Status:
Active
Serial Number:
99237066
Mark:
ACVYFI
Status:
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Mark Type:
TRADEMARK
Application Filing Date:
2025-06-16
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
ACVYFI

Goods And Services

For:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders;...
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
99236970
Mark:
LETBEV
Status:
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Mark Type:
TRADEMARK
Application Filing Date:
2025-06-16
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
LETBEV

Goods And Services

For:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders;...
International Classes:
005 - Primary Class
Class Status:
Active

OSHA's Inspections within Industry

Inspection Summary

Date:
2006-05-09
Type:
Planned
Address:
235 E 42 STREET, NEW YORK, NY, 10017
Safety Health:
Health
Scope:
NoInspection

Inspection Summary

Date:
2006-02-06
Type:
Planned
Address:
150 EAST 42ND STREET, NEW YORK, NY, 10017
Safety Health:
Health
Scope:
NoInspection

Inspection Summary

Date:
2001-05-02
Type:
Prog Other
Address:
630 FLUSHING AVENUE, BROOKLYN, NY, 11206
Safety Health:
Safety
Scope:
Partial

Inspection Summary

Date:
1984-01-31
Type:
Complaint
Address:
630 FLUSHING AVE, New York -Richmond, NY, 11206
Safety Health:
Safety
Scope:
Partial

Inspection Summary

Date:
1982-01-05
Type:
Planned
Address:
11 BARTLETT ST, New York -Richmond, NY, 11206
Safety Health:
Health
Scope:
Complete

Court Cases

Court Case Summary

Filing Date:
2025-01-31
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Neither plaintiff nor defendant demands jury
Nature Of Suit:
Other Civil Rights

Parties

Party Name:
DO NO HARM
Party Role:
Plaintiff
Party Name:
PFIZER INC.
Party Role:
Defendant

Court Case Summary

Filing Date:
2025-01-28
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Health Care / Pharma

Parties

Party Name:
CURRY
Party Role:
Plaintiff
Party Name:
PFIZER INC.
Party Role:
Defendant
Party Name:
Party Role:
Plaintiff

Court Case Summary

Filing Date:
2025-01-28
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Health Care / Pharma

Parties

Party Name:
HOMME
Party Role:
Plaintiff
Party Name:
PFIZER INC.
Party Role:
Defendant

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 19 Mar 2025

Sources: New York Secretary of State